⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 222 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$2.8T
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 1/3 (Toplam: 222)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $963.35B | $1072.43 | 2.89% |
| ABT | Abbott Laboratories | $224.36B | $128.90 | 0.28% |
| TMO | Thermo Fisher Scientific Inc. | $223.93B | $590.83 | 0.41% |
| DHR | Danaher Corporation | $162.49B | $226.78 | 0.74% |
| BSX | Boston Scientific Corporation | $150.59B | $101.58 | 0.61% |
| MDT | Medtronic plc | $135.10B | $105.33 | 0.30% |
| VRTX | Vertex Pharmaceuticals Incorporated | $111.27B | $433.61 | 0.33% |
| REGN | Regeneron Pharmaceuticals, Inc. | $80.58B | $780.19 | 0.56% |
| IDXX | IDEXX Laboratories, Inc. | $60.12B | $752.88 | 0.41% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $59.61B | $451.23 | 1.37% |
| ZTS | Zoetis Inc. | $56.53B | $128.28 | 0.46% |
| EW | Edwards Lifesciences Corporation | $50.91B | $86.71 | 0.05% |
| GEHC | GE HealthCare Technologies Inc. | $36.54B | $79.99 | 0.79% |
| NTRA | Natera, Inc. | $32.96B | $238.81 | 0.71% |
| DXCM | DexCom, Inc. | $24.82B | $63.45 | 1.47% |
| LH | Laboratory Corporation of America Holdings | $22.28B | $268.78 | 0.19% |
| DGX | Quest Diagnostics Incorporated | $21.14B | $189.18 | 0.27% |
| ILMN | Illumina, Inc. | $20.09B | $131.45 | 1.26% |
| EXAS | Exact Sciences Corporation | $19.19B | $101.29 | 0.16% |
| HOLX | Hologic, Inc. | $16.71B | $74.97 | 0.23% |
| MEDP | Medpace Holdings, Inc. | $16.69B | $592.46 | 2.33% |
| SOLV | Solventum Corporation | $14.79B | $85.26 | 0.01% |
| BBIO | BridgeBio Pharma, Inc. | $13.72B | $72.01 | 0.40% |
| GH | Guardant Health, Inc. | $13.46B | $108.42 | 0.58% |
| TEM | Tempus AI, Inc. | $13.40B | $78.16 | 1.23% |
| IONS | Ionis Pharmaceuticals, Inc. | $13.15B | $82.73 | 0.04% |
| EXEL | Exelixis, Inc. | $11.84B | $44.17 | 0.09% |
| TECH | Bio-Techne Corporation | $10.11B | $64.51 | 0.19% |
| RGEN | Repligen Corporation | $9.63B | $171.02 | 0.09% |
| RNA | Avidity Biosciences, Inc. | $9.41B | $71.70 | 0.20% |
| HSIC | Henry Schein, Inc. | $9.14B | $74.57 | 0.90% |
| BIO | Bio-Rad Laboratories, Inc. | $8.76B | $324.86 | 0.66% |
| DVA | DaVita Inc. | $8.45B | $119.68 | 0.35% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| AVTR | Avantor, Inc. | $8.00B | $11.73 | 0.09% |
| BRKR | Bruker Corporation | $7.40B | $48.81 | 0.45% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $7.29B | $52.70 | 8.68% |
| PTCT | PTC Therapeutics, Inc. | $6.90B | $85.99 | 0.30% |
| CHE | Chemed Corporation | $6.42B | $439.19 | 0.49% |
| RDNT | RadNet, Inc. | $6.39B | $82.79 | 0.00% |
| IRTC | iRhythm Technologies, Inc. | $6.06B | $188.01 | 0.72% |
| SHC | Sotera Health Company | $4.97B | $17.48 | 0.23% |
| KYMR | Kymera Therapeutics, Inc. | $4.88B | $67.88 | 0.03% |
| BLTE | Belite Bio, Inc | $4.80B | $137.44 | 6.03% |
| ADMA | ADMA Biologics, Inc. | $4.56B | $19.16 | 0.13% |
| SRRK | Scholar Rock Holding Corporation | $4.49B | $44.06 | 2.11% |
| PRAX | Praxis Precision Medicines, Inc. | $4.15B | $196.46 | 4.20% |
| LNTH | Lantheus Holdings, Inc. | $4.03B | $58.87 | 0.20% |
| HAE | Haemonetics Corporation | $3.97B | $81.35 | 0.74% |
| GRAL | GRAIL, Inc. | $3.86B | $110.39 | 0.21% |
| NVST | Envista Holdings Corp | $3.44B | $20.90 | 0.43% |
| CGON | CG Oncology, Inc. Common stock | $3.36B | $44.84 | 0.00% |
| RARE | Ultragenyx Pharmaceutical Inc. | $3.35B | $34.75 | 2.93% |
| AMED | Amedisys, Inc. | $3.32B | $100.99 | 0.01% |
| IDYA | IDEAYA Biosciences, Inc. | $3.12B | $35.62 | 0.72% |
| FOLD | Amicus Therapeutics, Inc. | $3.06B | $9.93 | 0.90% |
| ADPT | Adaptive Biotechnologies Corporation | $3.00B | $19.66 | 0.30% |
| DNLI | Denali Therapeutics Inc. | $2.86B | $19.47 | 0.36% |
| RCUS | Arcus Biosciences, Inc. | $2.82B | $26.10 | 2.11% |
| NUVB | Nuvation Bio Inc. | $2.75B | $8.04 | 0.37% |
| APLS | Apellis Pharmaceuticals, Inc. | $2.69B | $21.30 | 1.34% |
| CON | Concentra Group Holdings Parent, Inc. | $2.64B | $20.56 | 1.30% |
| IBRX | ImmunityBio, Inc. | $2.32B | $2.36 | 10.80% |
| TXG | 10x Genomics, Inc. | $2.32B | $18.82 | 0.37% |
| PGNY | Progyny, Inc. | $2.27B | $26.37 | 1.24% |
| MD | Pediatrix Medical Group, Inc. | $2.07B | $24.09 | 1.47% |
| TWST | Twist Bioscience Corporation | $1.91B | $32.01 | 0.98% |
| QDEL | QuidelOrtho Corporation | $1.86B | $27.35 | 0.55% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.86B | $4.63 | 4.99% |
| IMNM | Immunome, Inc. | $1.69B | $18.42 | 1.13% |
| AZTA | Azenta, Inc. | $1.63B | $35.56 | 1.96% |
| CERT | Certara, Inc. | $1.47B | $9.16 | 0.22% |
| KMTS | Kestra Medical Technologies, Ltd. Common Stock | $1.39B | $26.98 | 0.07% |
| BBNX | Beta Bionics, Inc. | $1.38B | $31.34 | 1.56% |
| NRIX | Nurix Therapeutics, Inc. | $1.36B | $17.68 | 2.79% |
| TDOC | Teladoc Health, Inc. | $1.35B | $7.59 | 1.88% |
| DVAX | Dynavax Technologies Corporation | $1.34B | $11.37 | 0.52% |
| NEOG | Neogen Corporation | $1.30B | $5.98 | 0.99% |
| ARDT | Ardent Health Partners, LLC | $1.26B | $8.78 | 2.98% |
| INBX | Inhibrx Biosciences, Inc. | $1.22B | $84.12 | 0.55% |
| TNGX | Tango Therapeutics, Inc. | $1.21B | $10.93 | 1.53% |
| FTRE | Fortrea Holdings Inc. | $1.15B | $12.71 | 0.63% |
| NVAX | Novavax, Inc. | $1.15B | $7.05 | 1.44% |
| ASTH | Astrana Health, Inc. | $1.12B | $23.04 | 0.04% |
| KURA | Kura Oncology, Inc. | $1.06B | $12.14 | 1.25% |
| OPK | OPKO Health, Inc. | $1.04B | $1.35 | 1.12% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $1.02B | $18.56 | 2.32% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $999.16M | $3.62 | 0.55% |
| PSNL | Personalis, Inc. | $952.82M | $10.73 | 0.09% |
| CDNA | CareDx, Inc | $919.14M | $17.87 | 0.34% |
| FLGT | Fulgent Genetics, Inc. | $907.97M | $29.58 | 1.89% |
| ABUS | Arbutus Biopharma Corporation | $845.61M | $4.40 | 0.23% |
| BFLY | Butterfly Network, Inc. | $783.05M | $3.10 | 0.65% |
| GERN | Geron Corporation | $753.26M | $1.18 | 0.84% |
| CTMX | CytomX Therapeutics, Inc. | $724.90M | $4.28 | 1.42% |
| CTKB | Cytek Biosciences, Inc. | $722.42M | $5.65 | 0.89% |
| IKNA | Ikena Oncology, Inc. | $718.82M | $17.16 | 1152.55% |
| MYGN | Myriad Genetics, Inc. | $711.16M | $7.63 | 0.39% |
| KROS | Keros Therapeutics, Inc. | $708.61M | $17.48 | 0.11% |
| GYRE | Gyre Therapeutics, Inc. | $704.05M | $7.75 | 1.27% |